世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000035209

ジェネリック医薬品の世界市場規模調査・予測:タイプ別、用途別、製品別、投与経路別、流通チャネル別、地域別の分析(2023年〜2030年)

Bizwit Research & Consulting LLP

Global Generic Pharmaceuticals Market Size study & Forecast, by Type ( Simple Generics, Specialty Generics, Biosimilars), by Application ( Central Nervous System Disorders, Respiratory Diseases, Hormones & Related Diseases, Gastrointestinal Diseases, Cardiovascular Diseases, Infectious Diseases and Others), by Product (Small Molecule, Large Molecule), By Route of Administration (Oral, Injectable, Inhalable and Others), by Distribution Channel (Online Pharmacies, Hospitals Pharmacies, Retail Pharmacies)and Regional Analysis, 2023-2030

発刊日 2023/05/20

言語英語

体裁PDF/200ページ

ライセンス/価格200ページ

0000035209

Single
Enterprise (Global Site)

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

世界のジェネリック医薬品市場は、2022年に約3,617億米ドルと評価され、予測期間の2022年から2029年には8.3%以上の健全な成長率で成長すると予測されています。ジェネリック医薬品は、用量、安全性、強さ、投与経路、品質、使用目的などの点で、先発医薬品と同一、または生物学的に同等な医薬品です。ジェネリック医薬品は、先発医薬品の特許失効後に製造されます。このため、他の製薬会社は、新薬の製造に必要な高額な研究開発に投資する必要がないため、同じ薬をより安価に製造・販売することができます。ジェネリック医薬品市場が拡大している背景には、ANDA承認の増加やジェネリック製品の上市、ジェネリック医薬品の使用を促進する政府の取り組みなどの要因が挙げられます。

ANDA承認数とジェネリック医薬品製品発売数の増加が市場成長の要因であり、米国FDAのジェネリック医薬品年次報告書(Generic Drugs Annual report)によると、ANDA承認数は2020年の948件から2021年には776件に増加しました。さらに、同じソースから、2021年末までに全体で100のANDAが承認されたと報告されています。各国政府は、ジェネリック医薬品の重要なプレーヤーが医薬品への支出を削減するための様々な機会を提供するプログラムを実施しています。例として、2021年にジェネリック医薬品を使用することで、アメリカ政府は医薬品コストを3億7,300万米ドル削減しました。AAM Generic Drug &Biosimilars Access &Savings Report 2021によると、処方箋の91%はジェネリック医薬品で満たされており、処方箋医薬品コストの18.2%を占めています。また、疾病負担の増加や老年人口の増加が、市場に有利な成長をもたらしています。しかし、ジェネリック医薬品の実際の価格に関する透明性の欠如が、市場の成長を妨げています。

ジェネリック医薬品の世界市場調査において考慮した主要地域は、アジア太平洋地域、北アメリカ、ヨーロッパ、ラテンアメリカ、中東・アフリカです。北アメリカは、主要な市場成長の存在と、この地域の疾患有病率の増加により、収益面で市場を独占しています。これらの増加する有利な政府の取り組みと、製品の発売数の増加やジェネリック医薬品への需要が、この地域の市場成長を牽引しています。一方、アジア太平洋は、老年人口や対象人口の増加、製品開拓のための共同研究の増加、主要参入企業の地理的拡大、政府機関や非営利団体の市場参入の積極化などの要因により、予測期間中に最も高いCAGRで成長すると予想されます。

  • 主要企業
    ➣ Teva Pharmaceutical Industries Ltd.
    ➣ Viatris Inc.
    ➣ Novartis AG
    ➣ Sun Pharmaceutical Industries Ltd.
    ➣ LUPIN
    ➣ AbbVie Inc. (Allergan)
    ➣ AstraZeneca
    ➣ 沢井製薬(Sawai Pharmaceutical Co., Ltd.)
    ➣ Hikma Pharmaceuticals PLC
    ➣ Dr. Reddy’s Laboratories Ltd.
  • 調査対象年
    ➣ 実績データ - 2020 - 2021年
    ➣ 推計基準年 - 2022年
    ➣ 予測期間 - 2023 - 2030年

本調査の目的は、近年における様々なセグメント・国の市場規模を定義し、今後数年間の価値を予測することです。本レポートは、調査対象国における産業の質的・量的な側面を取り込むように設計されています。

さらに、市場の今後の成長を決定づける推進要因や課題などの重要な側面に関する詳細情報も提供しています。さらに、主要企業の競争環境と製品提供の詳細な分析とともに、利害関係者が投資するためのミクロ市場の潜在的な機会も組み込んでいます。

  • 市場セグメント
    ➣ タイプ別
      ◇ シンプルジェネリック医薬品
      ◇ 特殊ジェネリック医薬品
      ◇ バイオシミラー
    ➣ 用途別
      ◇ 中枢神経系疾患
      ◇ 呼吸器系疾患
      ◇ ホルモン関連疾患
      ◇ 消化器系疾患
      ◇ 心血管疾患
      ◇ 感染症
      ◇ その他
    ➣ 製品別
      ◇ 低分子
      ◇ 高分子
    ➣ 投与経路別
      ◇ 経口剤
      ◇ 注射剤
      ◇ 吸入剤
      ◇ その他
    ➣ 流通チャネル別
      ◇ オンライン薬局
      ◇ 小売薬局
      ◇ 病院薬局
    ➣ 地域別
      ◇ 北アメリカ
       ✓ アメリカ
       ✓ カナダ
      ◇ ヨーロッパ
       ✓ イギリス
       ✓ ドイツ
       ✓ フランス
       ✓ スペイン
       ✓ イタリア
       ✓ その他のヨーロッパ
      ◇ アジア太平洋地域
       ✓ 中国
       ✓ インド
       ✓ 日本
       ✓ オーストラリア
       ✓ 韓国
       ✓ その他のAPAC
      ◇ ラテンアメリカ
       ✓ ブラジル
       ✓ メキシコ
       ✓ その他のラテンアメリカ
      ◇ 世界のその他の地域
      ◇ 中東・アフリカ
       ✓ サウジアラビア
       ✓ 南アフリカ
       ✓ その他の中東・アフリカ

レポート詳細

目次

Table of Contents

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
1.2.1. Generic Pharmaceuticals Market, by Region, 2020-2030 (USD Billion)
1.2.2. Generic Pharmaceuticals Market, by Type, 2020-2030 (USD Billion)
1.2.3. Generic Pharmaceuticals Market, by Application, 2020-2030 (USD Billion)
1.2.4. Generic Pharmaceuticals Market, by Product, 2020-2030 (USD Billion)
1.2.5. Generic Pharmaceuticals Market, by Route of Administration, 2020-2030 (USD Billion)
1.2.6. Generic Pharmaceuticals Market, by Distribution Channel, 2020-2030 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption

Chapter 2. Global Generic Pharmaceuticals Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates

Chapter 3. Global Generic Pharmaceuticals Market Dynamics
3.1. Generic Pharmaceuticals Market Impact Analysis (2020-2030)
3.1.1. Market Drivers
3.1.1.1. Increasing ANDA approval and Generic Product Launches
3.1.1.2. Government initiatives to promote usage of generics
3.1.2. Market Challenges
3.1.2.1. High Cost of Generic Pharmaceuticals
3.1.2.2. Pricing issues
3.1.3. Market Opportunities
3.1.3.1. Increasing Disease Burden
3.1.3.2. Rising Geriatric Population

Chapter 4. Global Generic Pharmaceuticals Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter's 5 Force Impact Analysis
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion

Chapter 5. Global Generic Pharmaceuticals Market, by Type
5.1. Market Snapshot
5.2. Global Generic Pharmaceuticals Market by Type, Performance - Potential Analysis
5.3. Global Generic Pharmaceuticals Market Estimates & Forecasts by Type 2020-2030 (USD Billion)
5.4. Generic Pharmaceuticals Market, Sub Segment Analysis
5.4.1. Simple Generics
5.4.2. Specialty Generics
5.4.3. Biosimilars

Chapter 6. Global Generic Pharmaceuticals Market, by Application
6.1. Market Snapshot
6.2. Global Generic Pharmaceuticals Market by Application, Performance - Potential Analysis
6.3. Global Generic Pharmaceuticals Market Estimates & Forecasts by Application 2020-2030 (USD Billion)
6.4. Generic Pharmaceuticals Market, Sub Segment Analysis
6.4.1. Central Nervous System Disorders
6.4.2. Respiratory Diseases
6.4.3. Hormones & Related Diseases
6.4.4. Gastrointestinal Diseases
6.4.5. Cardiovascular Diseases
6.4.6. Infectious Diseases
6.4.7. Others

Chapter 7. Global Generic Pharmaceuticals Market, by Product
7.1. Market Snapshot
7.2. Global Generic Pharmaceuticals Market by Product, Performance - Potential Analysis
7.3. Global Generic Pharmaceuticals Market Estimates & Forecasts by Product 2020-2030 (USD Billion)
7.4. Generic Pharmaceuticals Market, Sub Segment Analysis
7.4.1. Small Molecule
7.4.2. Large Molecule

Chapter 8. Global Generic Pharmaceuticals Market, by Route of Administration
8.1. Market Snapshot
8.2. Global Generic Pharmaceuticals Market by Route of Administration, Performance - Potential Analysis
8.3. Global Generic Pharmaceuticals Market Estimates & Forecasts by Route of Administration 2020-2030 (USD Billion)
8.4. Generic Pharmaceuticals Market, Sub Segment Analysis
8.4.1. Oral
8.4.2. Injectable
8.4.3. Inhalable
8.4.4. Others

Chapter 9. Global Generic Pharmaceuticals Market, by Distribution Channel
9.1. Market Snapshot
9.2. Global Generic Pharmaceuticals Market by Distribution Channel, Performance - Potential Analysis
9.3. Global Generic Pharmaceuticals Market Estimates & Forecasts by Distribution channel 2020-2030 (USD Billion)
9.4. Generic Pharmaceuticals Market, Sub Segment Analysis
9.4.1. Online Pharmacies
9.4.2. Retail Pharmacies
9.4.3. Hospital Pharmacies

Chapter 10. Global Generic Pharmaceuticals Market, Regional Analysis
10.1. Top Leading Countries
10.2. Top Emerging Countries
10.3. Generic Pharmaceuticals Market, Regional Market Snapshot
10.4. North America Generic Pharmaceuticals Market
10.4.1. U.S. Generic Pharmaceuticals Market
10.4.1.1. Type breakdown estimates & forecasts, 2020-2030
10.4.1.2. Application breakdown estimates & forecasts, 2020-2030
10.4.1.3. Product breakdown estimates & forecasts, 2020-2030
10.4.1.4. Route of Administration breakdown estimates & forecasts, 2020-2030 10.4.1.5. Distribution Channel breakdown estimates & forecasts, 2020-2030
10.4.2. Canada Generic Pharmaceuticals Market
10.5. Europe Generic Pharmaceuticals Market Snapshot
10.5.1. U.K. Generic Pharmaceuticals Market
10.5.2. Germany Generic Pharmaceuticals Market
10.5.3. France Generic Pharmaceuticals Market
10.5.4. Spain Generic Pharmaceuticals Market
10.5.5. Italy Generic Pharmaceuticals Market
10.5.6. Rest of Europe Generic Pharmaceuticals Market
10.6. Asia-Pacific Generic Pharmaceuticals Market Snapshot
10.6.1. China Generic Pharmaceuticals Market
10.6.2. India Generic Pharmaceuticals Market
10.6.3. Japan Generic Pharmaceuticals Market
10.6.4. Australia Generic Pharmaceuticals Market
10.6.5. South Korea Generic Pharmaceuticals Market
10.6.6. Rest of Asia Pacific Generic Pharmaceuticals Market
10.7. Latin America Generic Pharmaceuticals Market Snapshot
10.7.1. Brazil Generic Pharmaceuticals Market
10.7.2. Mexico Generic Pharmaceuticals Market
10.8. Rest of The World Generic Pharmaceuticals Market

Chapter 11. Competitive Intelligence
11.1. Key Company SWOT Analysis
11.1.1. Company 1
11.1.2. Company 2
11.1.3. Company 3
11.2. Top Market Strategies
11.3. Company Profiles
11.3.1. Teva Pharmaceutical Industries Ltd.
11.3.1.1. Key Information
11.3.1.2. Overview
11.3.1.3. Financial (Subject to Data Availability)
11.3.1.4. Product Summary
11.3.1.5. Recent Developments
11.3.2. Viatris Inc.
11.3.3. Novartis AG
11.3.4. Sun Pharmaceutical Industries Ltd.
11.3.5. LUPIN
11.3.6. AbbVie Inc. (Allergan)
11.3.7. AstraZeneca
11.3.8. Sawai Pharmaceutical Co., Ltd.
11.3.9. Hikma Pharmaceuticals PLC
11.3.10. Dr. Reddy's Laboratories Ltd.

Chapter 12. Research Process
12.1. Research Process
12.1.1. Data Mining
12.1.2. Analysis
12.1.3. Market Estimation
12.1.4. Validation
12.1.5. Publishing
12.2. Research Attributes
12.3. Research Assumption

LIST OF TABLES
TABLE 1. Global Generic Pharmaceuticals Market, report scope
TABLE 2. Global Generic Pharmaceuticals Market estimates & forecasts by Region 2020-2030 (USD Billion)
TABLE 3. Global Generic Pharmaceuticals Market estimates & forecasts by Type 2020-2030 (USD Billion)
TABLE 4. Global Generic Pharmaceuticals Market estimates & forecasts by Application 2020-2030 (USD Billion)
TABLE 5. Global Generic Pharmaceuticals Market estimates & forecasts by Product 2020-2030 (USD Billion)
TABLE 6. Global Generic Pharmaceuticals Market estimates & forecasts by Route of Administration 2020-2030 (USD Billion)
TABLE 7. Global Generic Pharmaceuticals Market estimates & forecasts by Distribution Channel 2020-2030 (USD Billion)
TABLE 8. Global Generic Pharmaceuticals Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 9. Global Generic Pharmaceuticals Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 10. Global Generic Pharmaceuticals Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 11. Global Generic Pharmaceuticals Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 12. Global Generic Pharmaceuticals Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 13. Global Generic Pharmaceuticals Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 14. Global Generic Pharmaceuticals Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 15. Global Generic Pharmaceuticals Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 16. Global Generic Pharmaceuticals Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 17. Global Generic Pharmaceuticals Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 18. U.S. Generic Pharmaceuticals Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 19. U.S. Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 20. U.S. Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 21. Canada Generic Pharmaceuticals Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 22. Canada Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 23. Canada Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 24. UK Generic Pharmaceuticals Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 25. UK Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 26. UK Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 27. Germany Generic Pharmaceuticals Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 28. Germany Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 29. Germany Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 30. France Generic Pharmaceuticals Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 31. France Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 32. France Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 33. Italy Generic Pharmaceuticals Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 34. Italy Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 35. Italy Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 36. Spain Generic Pharmaceuticals Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 37. Spain Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 38. Spain Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 39. RoE Generic Pharmaceuticals Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 40. RoE Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 41. RoE Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 42. China Generic Pharmaceuticals Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 43. China Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 44. China Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 45. India Generic Pharmaceuticals Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 46. India Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 47. India Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 48. Japan Generic Pharmaceuticals Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 49. Japan Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 50. Japan Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 51. South Korea Generic Pharmaceuticals Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 52. South Korea Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 53. South Korea Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 54. Australia Generic Pharmaceuticals Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 55. Australia Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 56. Australia Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 57. RoAPAC Generic Pharmaceuticals Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 58. RoAPAC Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 59. RoAPAC Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 60. Brazil Generic Pharmaceuticals Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 61. Brazil Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 62. Brazil Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 63. Mexico Generic Pharmaceuticals Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 64. Mexico Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 65. Mexico Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 66. RoLA Generic Pharmaceuticals Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 67. RoLA Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 68. RoLA Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 69. Saudi Arabia Generic Pharmaceuticals Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 70. South Africa Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 71. RoMEA Generic Pharmaceuticals Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 72. List of secondary sources, used in the study of global Generic Pharmaceuticals Market
TABLE 73. List of primary sources, used in the study of global Generic Pharmaceuticals Market
TABLE 74. Years considered for the study
TABLE 75. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES
FIG 1. Global Generic Pharmaceuticals Market, research methodology
FIG 2. Global Generic Pharmaceuticals Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Generic Pharmaceuticals Market, key trends 2022
FIG 5. Global Generic Pharmaceuticals Market, growth prospects 2023-2030
FIG 6. Global Generic Pharmaceuticals Market, porters 5 force model
FIG 7. Global Generic Pharmaceuticals Market, pest analysis
FIG 8. Global Generic Pharmaceuticals Market, value chain analysis
FIG 9. Global Generic Pharmaceuticals Market by segment, 2020 & 2030 (USD Billion)
FIG 10. Global Generic Pharmaceuticals Market by segment, 2020 & 2030 (USD Billion)
FIG 11. Global Generic Pharmaceuticals Market by segment, 2020 & 2030 (USD Billion)
FIG 12. Global Generic Pharmaceuticals Market by segment, 2020 & 2030 (USD Billion)
FIG 13. Global Generic Pharmaceuticals Market by segment, 2020 & 2030 (USD Billion)
FIG 14. Global Generic Pharmaceuticals Market, regional snapshot 2020 & 2030
FIG 15. North America Generic Pharmaceuticals Market 2020 & 2030 (USD Billion)
FIG 16. Europe Generic Pharmaceuticals Market 2020 & 2030 (USD Billion)
FIG 17. Asia pacific Generic Pharmaceuticals Market 2020 & 2030 (USD Billion)
FIG 18. Latin America Generic Pharmaceuticals Market 2020 & 2030 (USD Billion)
FIG 19. Middle East & Africa Generic Pharmaceuticals Market 2020 & 2030 (USD Billion)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

この商品のレポートナンバー

0000035209

TOP